|
C2ORF68 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.968200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.828360E-01 |
| Normal-vs-Stage2 |
2.060200E-01 |
| Normal-vs-Stage3 |
1.380820E-01 |
| Normal-vs-Stage4 |
5.042800E-01 |
| Stage1-vs-Stage2 |
4.472800E-01 |
| Stage1-vs-Stage3 |
4.534200E-01 |
| Stage1-vs-Stage4 |
6.562200E-01 |
| Stage2-vs-Stage3 |
7.833400E-01 |
| Stage2-vs-Stage4 |
9.102000E-01 |
| Stage3-vs-Stage4 |
8.097600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.776100E-02 |
| Normal-vs-AfricanAmerican |
9.867900E-02 |
| Normal-vs-Asian |
6.659400E-01 |
| Caucasian-vs-AfricanAmerican |
8.817800E-01 |
| Caucasian-vs-Asian |
9.291800E-01 |
| AfricanAmerican-vs-Asian |
8.918200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.852300E-02 |
| Normal-vs-Female |
6.257000E-03 |
| Male-vs-Female |
1.038010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.028400E-01 |
| Normal-vs-Extreme_Weight |
3.164400E-01 |
| Normal-vs-Obese |
1.828140E-02 |
| Normal-vs-Extreme_Obese |
4.217600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.852800E-01 |
| Normal_Weight-vs-Obese |
4.406000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.895600E-01 |
| Extreme_Weight-vs-Obese |
1.163770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.434800E-01 |
| Obese-vs-Extreme_Obese |
6.255000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.636100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.038490E-03 |
| Normal-vs-Age(61-80Yrs) |
3.944000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.343400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.311800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.583700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.332300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.735200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.995500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.741400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.404200E-03 |
| Normal-VS-Type2 PRCC |
5.959200E-01 |
| Normal-VS-KIRP CIMP |
1.835960E-01 |
| Normal-VS-Unclassified PRCC |
2.321700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.875800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.793200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.158800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.178400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.314410E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.578200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.738400E-01 |
| Normal-vs-N1 |
1.069800E-01 |
| Normal-vs-N2 |
3.531600E-01 |
| N0-vs-N1 |
1.240000E-01 |
| N0-vs-N2 |
5.155800E-01 |
| N1-vs-N2 |
7.257600E-01 |
|
|
